Yes, Twyneo is FDA approved. The U.S. Food and Drug Administration (FDA) approved Twyneo for use in the treatment of acne vulgaris on July 26, 2021. This approval allows the medication to be prescribed and used in the United States for its intended purposes.
Twyneo combines benzoyl peroxide and tretinoin in a topical cream form, with concentrations of 3% and 0.1%, respectively. It is used to treat acne vulgaris in both adults and children aged 9 years and older. The combination of these two ingredients helps to reduce acne by addressing multiple factors that contribute to the condition, such as bacterial growth, clogged pores, and inflammation.
Twyneo should be applied as follows:
While Twyneo is generally well-tolerated, it can cause side effects. Common side effects include:
Severe side effects may include signs of an allergic reaction, such as hives, difficulty breathing, and swelling of the face, lips, tongue, or throat. If severe side effects occur, seek medical attention immediately.
Before using Twyneo, it is important to consider the following precautions:
Twyneo is an FDA-approved topical treatment for acne vulgaris, combining benzoyl peroxide and tretinoin for effective acne management. It is essential to follow the prescribed usage instructions and take necessary precautions to avoid side effects and ensure the best results. Always consult with a healthcare provider before starting any new medication.
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!